Customer Support: 131 242

  • Shopping Cart
    There are no items in your cart
Please Select Your Option.
It seems you are away from your “home” country. Do you wish to be re-directed to your “home” store? If you choose “YES”, you will see product, taxation, and shipping information relevant to your country. If you select “NO”, the current store's conditions will apply.
We noticed you’re not on the correct regional site. Switch to our AMERICAS site for the best experience.
Dismiss alert

CLSI NBS07:2017(R2022)

Current

Current

The latest, up-to-date edition.

Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid α-Glucosidase Activity Assays

Available format(s)

Hardcopy , PDF

Language(s)

English

Published date

01-06-2022

This report discusses the detection of Pompe disease (PD), also known as glycogen storage disease type II, by population-based newborn dried blood spot (DBS) screening, and focuses on enzyme activity assays for detecting PD.

DocumentType
Standard
ISBN
1-56238-814-2
Pages
70
PublisherName
Clinical Laboratory Standards Institute
Status
Current
Supersedes

$526.32
Including GST where applicable

Access your standards online with a subscription

Features

  • Simple online access to standards, technical information and regulations.

  • Critical updates of standards and customisable alerts and notifications.

  • Multi-user online standards collection: secure, flexible and cost effective.